NKTX logo

Nkarta (NKTX) Company Overview

Profile

Full Name:

Nkarta, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 10, 2020

Indexes:

Not included

Description:

Nkarta, Inc. is a biotechnology company focused on developing innovative cell therapies for cancer treatment. They use engineered natural killer (NK) cells to target and destroy cancer cells, aiming to improve patient outcomes and provide new options for those with difficult-to-treat cancers.

Events Calendar

Earnings

Next earnings date:

Mar 21, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 21, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Nov 21, 24 Mizuho
Outperform
Nov 11, 24 HC Wainwright & Co.
Buy
Nov 8, 24 Needham
Buy
Aug 15, 24 HC Wainwright & Co.
Buy
Aug 14, 24 Raymond James
Strong Buy
Aug 14, 24 Needham
Buy
Jul 24, 24 HC Wainwright & Co.
Buy
Jun 28, 24 Needham
Buy
Jun 27, 24 HC Wainwright & Co.
Buy
May 13, 24 Needham
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Nkarta?
  • Does Nkarta pay dividends?
  • What sector is Nkarta in?
  • What industry is Nkarta in?
  • What country is Nkarta based in?
  • When did Nkarta go public?
  • Is Nkarta in the S&P 500?
  • Is Nkarta in the NASDAQ 100?
  • Is Nkarta in the Dow Jones?
  • When was Nkarta's last earnings report?
  • When does Nkarta report earnings?
  • Should I buy Nkarta stock now?

What is the ticker symbol for Nkarta?

The ticker symbol for Nkarta is NASDAQ:NKTX

Does Nkarta pay dividends?

No, Nkarta does not pay dividends

What sector is Nkarta in?

Nkarta is in the Healthcare sector

What industry is Nkarta in?

Nkarta is in the Biotechnology industry

What country is Nkarta based in?

Nkarta is headquartered in United States

When did Nkarta go public?

Nkarta's initial public offering (IPO) was on July 10, 2020

Is Nkarta in the S&P 500?

No, Nkarta is not included in the S&P 500 index

Is Nkarta in the NASDAQ 100?

No, Nkarta is not included in the NASDAQ 100 index

Is Nkarta in the Dow Jones?

No, Nkarta is not included in the Dow Jones index

When was Nkarta's last earnings report?

Nkarta's most recent earnings report was on Nov 7, 2024

When does Nkarta report earnings?

The next expected earnings date for Nkarta is Mar 21, 2025

Should I buy Nkarta stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions